Chronic treatment with vasopressin analogues alters affinity of vasopressin receptors in the septum and amygdala of the rat brain

Michael W. Swank, Daniel M. Dorsa

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Accurel devices were used to administer AVP or AVP-antagonist into the lateral ventricle of the rat brain for 7 days. Neither AVP nor antagonist altered total binding site concentration in either septum or amygdala. However, treatment with antagonist caused a marked decrease in the affinity of the receptor for agonist in both the septum and amygdala.

Original languageEnglish (US)
Pages (from-to)342-344
Number of pages3
JournalBrain research
Volume544
Issue number2
DOIs
StatePublished - Mar 29 1991

Keywords

  • Accurel colloidion device
  • Antagonist
  • Brain
  • Vasopressin receptor

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Fingerprint Dive into the research topics of 'Chronic treatment with vasopressin analogues alters affinity of vasopressin receptors in the septum and amygdala of the rat brain'. Together they form a unique fingerprint.

  • Cite this